Atlas Trials

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Clinical trial NCT03422874 · WITHDRAWN

Trial details

NCT number
NCT03422874
Sponsor
Dartmouth-Hitchcock Medical Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
NeoplasmsLymphoma
Start date
2016-08-01
Primary completion
2017-08-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.